conversion of 111000 warrants into Equity Shares
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shelter Pharma Ltd has approved the conversion of 111,000 convertible equity warrants into 111,000 fully paid-up equity shares of face value ₹10 each. The conversion was exercised by one non-promoter investor, Rishabh Nayanbhai Sharma, who paid the remaining 75% of the issue price (₹31.6875 per share), totaling ₹3,517,312.50. The original warrants were allotted at ₹42.25 each (including ₹32.25 premium) as part of a preferential allotment of 88,08,000 warrants approved by shareholders in July 2025. Following this partial conversion, 129,000 warrants remain outstanding for this investor. The company's paid-up share capital increased from ₹16.73 crore to ₹16.84 crore as a result.
This is a minor equity dilution (111,000 shares out of 16.8 million total). The conversion brings fresh capital of about ₹35 lakh and signals continued confidence from non-promoter investors in the company's prospects.